Forte Capital LLC ADV Sells 1,484 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Forte Capital LLC ADV trimmed its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 3.9% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 36,303 shares of the medical equipment provider's stock after selling 1,484 shares during the period. Intuitive Surgical makes up approximately 2.1% of Forte Capital LLC ADV's investment portfolio, making the stock its 12th largest position. Forte Capital LLC ADV's holdings in Intuitive Surgical were worth $18,949,000 at the end of the most recent reporting period.

Other hedge funds have also recently bought and sold shares of the company. Bennett Selby Investments LP increased its position in shares of Intuitive Surgical by 3.9% during the 4th quarter. Bennett Selby Investments LP now owns 449 shares of the medical equipment provider's stock valued at $234,000 after purchasing an additional 17 shares during the last quarter. LVW Advisors LLC grew its position in Intuitive Surgical by 1.3% during the fourth quarter. LVW Advisors LLC now owns 1,448 shares of the medical equipment provider's stock valued at $756,000 after buying an additional 19 shares during the period. Wesbanco Bank Inc. grew its position in Intuitive Surgical by 1.6% during the fourth quarter. Wesbanco Bank Inc. now owns 1,216 shares of the medical equipment provider's stock valued at $635,000 after buying an additional 19 shares during the period. Journey Strategic Wealth LLC increased its holdings in Intuitive Surgical by 1.9% during the fourth quarter. Journey Strategic Wealth LLC now owns 1,039 shares of the medical equipment provider's stock worth $542,000 after buying an additional 19 shares during the last quarter. Finally, FSM Wealth Advisors LLC boosted its stake in Intuitive Surgical by 3.7% in the fourth quarter. FSM Wealth Advisors LLC now owns 526 shares of the medical equipment provider's stock valued at $275,000 after acquiring an additional 19 shares during the last quarter. 83.64% of the stock is owned by institutional investors.

Intuitive Surgical Stock Performance

ISRG traded up $1.84 on Monday, reaching $593.63. The company had a trading volume of 653,802 shares, compared to its average volume of 1,693,389. Intuitive Surgical, Inc. has a 52-week low of $364.17 and a 52-week high of $616.00. The company has a market cap of $211.44 billion, a price-to-earnings ratio of 92.53, a P/E/G ratio of 5.85 and a beta of 1.39. The business has a 50 day simple moving average of $565.45 and a 200 day simple moving average of $525.60.

Insiders Place Their Bets

In related news, Director Amal M. Johnson sold 4,635 shares of Intuitive Surgical stock in a transaction on Tuesday, January 28th. The shares were sold at an average price of $566.60, for a total value of $2,626,191.00. Following the transaction, the director now owns 12,275 shares in the company, valued at $6,955,015. This trade represents a 27.41 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, CFO Jamie Samath sold 108 shares of Intuitive Surgical stock in a transaction dated Tuesday, November 26th. The stock was sold at an average price of $542.06, for a total value of $58,542.48. Following the completion of the transaction, the chief financial officer now owns 8,757 shares in the company, valued at approximately $4,746,819.42. This represents a 1.22 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 6,348 shares of company stock valued at $3,587,582 over the last 90 days. Insiders own 0.90% of the company's stock.

Analyst Upgrades and Downgrades

ISRG has been the subject of several research analyst reports. CICC Research started coverage on shares of Intuitive Surgical in a research note on Monday, January 27th. They set a "neutral" rating and a $550.00 price target for the company. Leerink Partners raised their target price on Intuitive Surgical from $490.00 to $548.00 in a research report on Monday, January 27th. JPMorgan Chase & Co. upped their price target on Intuitive Surgical from $575.00 to $675.00 and gave the company an "overweight" rating in a research report on Friday, January 24th. Royal Bank of Canada lifted their price objective on Intuitive Surgical from $611.00 to $641.00 in a report on Monday, January 27th. Finally, Barclays upped their price objective on shares of Intuitive Surgical from $610.00 to $674.00 in a report on Monday, January 27th. One analyst has rated the stock with a sell rating, five have issued a hold rating and sixteen have assigned a buy rating to the company. According to MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and a consensus target price of $613.10.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.